ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmoloģiskie līdzekļi - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
ocuvision plus (2018.) kapsula
symbiofarm sp.z.o.o. - kapsula
penisex (paziņots 2010.) kapsula
joydivision international ag - kapsula
guarana plus tropfen (paziņots 2010.) šķidrums
joydivision international ag - šķidrums
sexotic (paziņots 2010.) šķidrums
joydivision international ag - šķidrums
sexcalibur (paziņots 2010.) šķidrums
joydivision international ag - šķidrums
obsession impulse (paziņots 2010.) šķidrums
joydivision international ag - šķidrums
sex-vitamin-tropfen (paziņots 2010.) šķidrums
joydivision international ag - šķidrums